Open label clinical trial with rituximab (MabThera) in ankylosing spondylitis
Latest Information Update: 10 Nov 2021
At a glance
- Drugs Rituximab (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 16 Mar 2007 New trial record.
Latest Information Update: 10 Nov 2021